{"product_id":"cartalax","title":"Cartalax","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCartalax\u003c\/strong\u003e (also known as \u003cstrong\u003eAED peptide\u003c\/strong\u003e or \u003cstrong\u003eCartalax bioregulator\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic tripeptide\u003c\/strong\u003e with the sequence Ala-Glu-Asp, developed as a tissue-specific peptide bioregulator within the cytogen\/bioregulator peptide class pioneered by Russian researchers. This research compound has attracted scientific interest for its potential \u003cstrong\u003echondroprotective\u003c\/strong\u003e, \u003cstrong\u003eregenerative\u003c\/strong\u003e, and \u003cstrong\u003eanti-aging\u003c\/strong\u003e effects on cartilage and connective tissues. Preliminary preclinical studies suggest that Cartalax may normalize gene expression in chondrocytes, support extracellular matrix synthesis, reduce age-related degenerative changes in joint tissues, and promote tissue homeostasis. Researchers utilize Cartalax in laboratory and animal models to investigate mechanisms of cartilage repair, osteoarthritis-like conditions, joint aging, and short-peptide regulation of connective tissue. As a research-grade compound, Cartalax is intended exclusively for in vitro and animal studies. Scientists value its low molecular weight, high tissue specificity for cartilage, and utility in studying peptide-mediated epigenetic and transcriptional control in musculoskeletal tissues.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eCartilage and Joint Tissue Support\u003c\/strong\u003e — Preclinical investigations indicate Cartalax influences chondrocyte activity, promotes synthesis of collagen and proteoglycans, and helps maintain cartilage matrix integrity in models of joint degeneration and aging.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChondroprotection and Anti-Degenerative Effects\u003c\/strong\u003e — Studies explore its potential to counteract age-related and injury-induced cartilage breakdown, reduce inflammatory markers in joint tissues, and support structural preservation in osteoarthritis-like models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConnective Tissue and Extracellular Matrix Regulation\u003c\/strong\u003e — Research highlights effects on fibroblasts and matrix remodeling processes, with implications for broader connective tissue health beyond pure cartilage.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGene Expression and Epigenetic Modulation\u003c\/strong\u003e — As a short peptide bioregulator, Cartalax is studied for its ability to normalize expression of genes involved in tissue-specific differentiation, protein synthesis, and cellular stress responses in cartilage cells.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAging and Regenerative Research\u003c\/strong\u003e — Investigations examine its role in mitigating age-related decline in joint function and supporting recovery in models of musculoskeletal aging and overuse.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Omni Peptides","offers":[{"title":"20 MG","offer_id":51002104119543,"sku":null,"price":500.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/cartalax_20mg.png?v=1786035057","url":"https:\/\/dubaipeptides.ae\/products\/cartalax","provider":"Dubai Peptides","version":"1.0","type":"link"}